The further rebound in the Q2 Tankan supports our view that the economy’s disappointing start to the year won’t prevent vaccines driving a strong rebound in the second half of the year. And firms’ upbeat capital spending plans bolster our view that business investment will soon recover sharply.
Subscriber content
Read this in full, free
Start a free trial and use one of your 10 free starter credits to unlock this piece.